Hanson Kristopher 4

What Happened Kristopher Hanson, General Counsel of MapLight Therapeutics, had 26,007 shares withheld by the issuer on 2026-01-27 to satisfy tax withholding obligations related to the settlement of restricted stock units (RSUs). The filing shows a per-share value of $17.98, for a total of $467,606. This was a tax-withholding disposition (code F), not an open-market sale or new purchase.

Key Details

• Transaction date: January 27, 2026
• Price used for withholding: $17.98 per share
• Shares withheld/disposed: 26,007 (reported as disposition under tax withholding) — total value ~$467,606
• Shares owned after the transaction: not specified in the provided filing summary
• Footnote: The shares were withheld to satisfy tax obligations on RSU settlement. Retained shares remain subject to a 180-day lock-up from the IPO prospectus date (Oct 26, 2025), which generally prevents sales until ~Apr 23, 2026.
• Filing timeliness: Form 4 filed on Jan 29, 2026 for the Jan 27 transaction (within the typical two-business-day filing window).

Context This was a routine tax-withholding transaction tied to RSU settlement (often called a cashless or share-withholding method) rather than a discretionary sale on the open market. Such withholdings are common and generally do not by themselves indicate insider sentiment about the stock. The lock-up noted in the footnote restricts resale of the retained securities until the lock-up period expires.